Personal Injury and Damage Ascertainment under Civil Law

State-of-the-Art International Guidelines

  • Santo Davide Ferrara
  • Rafael  Boscolo-Berto
  • Guido Viel

Table of contents

  1. Front Matter
    Pages i-xxxviii
  2. Juridical and Methodological Overview

    1. Front Matter
      Pages 1-1
    2. Santo Davide Ferrara, Guido Viel, Rafael Boscolo-Berto
      Pages 3-15
    3. Santo Davide Ferrara, Gian Aristide Norelli, Riccardo Zoia
      Pages 17-35
    4. Santo Davide Ferrara
      Pages 37-51
  3. Medico-Legal Ascertainment of Personal Injury and Damage Under Civil-Tort Law: Continental Overview – Europe

    1. Front Matter
      Pages 69-69
    2. Claudio Hernàndez-Cueto
      Pages 81-100
    3. Eric Baccino, Jean Sebastien Raul
      Pages 101-109
    4. Yvo Vermylen, Katja De Munnynck
      Pages 133-156
    5. Jan Buitenhuis, Wout E. L. De Boer
      Pages 157-164
    6. Vera Sterzik, Axel Muttray, Peter Weiß, Elisabeth Mützel
      Pages 195-208
    7. Eva Keller, Agnes Dósa, Andras Sarvary, Krisztian Csapó, Peter Banczerowski
      Pages 209-236
  4. Medico-legal Ascertainment of Personal Injury and Damage Under Civil-Tort Law: Continental Overview – America

    1. Front Matter
      Pages 269-269

About this book

Introduction

This volume serves to provide an international overview of personal injury compensation in different geographical areas (15 countries already included), with a special focus on the methods used to ascertain the injury and the related damages. It also goes on to clarify the logical and methodological steps required for a sequential, in-depth ascertainment of any traumatic event and the related personal damage, both pecuniary and non-pecuniary. Personal injury is a legal term for an injury to the body, mind or emotions suffered by the plaintiff under tort and/or civil law regulations. Damages related to the injury can be pecuniary or non-pecuniary in nature. Although several comparative studies and research projects on tort and civil law and personal injury claims aimed at developing new tools for promoting harmonization of private law have been performed at an international level, heterogeneity and divergences still exist in the definition and compensation of personal injury and damage across different national legislative systems. The starting point for any awarding procedure should be a medical, or rather a medico-legal, assessment to gain evidence on the trauma or event causing the injury, the mechanism of injury, the pre-existing health status of the injured party, and the health consequences of the injury (temporary and permanent impairment, work incapacity, etc.). In order to pursue the ultimate goal of an international harmonization of personal injury compensation, it is of upmost importance to define the quality requirements for the medico-legal ascertainment methodology, which are essential for guaranteeing the objectivity, rigor, and reproducibility of the data and the evidence collection procedure. Currently, there are no supra-national medico-legal guidelines dealing with the ascertainment methodology of personal injury and damage under tort and civil law. 

Keywords

Personal injury Personal damage Civil law Pecuniary losses Guidelines Non-pecuniary losses;

Editors and affiliations

  • Santo Davide Ferrara
    • 1
  • Rafael  Boscolo-Berto
    • 2
  • Guido Viel
    • 3
  1. 1.Department of Legal and Occupational Medicine, Toxicology and Public HealthUniversity-Hospital of PadovaPadovaItaly
  2. 2.Department of Legal and Occupational Medicine, Toxicology and Public HealthUniversity-Hospital of PadovaPadovaItaly
  3. 3.Department of Legal and Occupational Medicine, Toxicology and Public HealthUniversity-Hospital of PadovaPadovaItaly

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-29812-2
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-319-29810-8
  • Online ISBN 978-3-319-29812-2
  • About this book
Industry Sectors
Biotechnology
Pharma